Comprehensive Multimorbidity Patterns in Older Patients Are Associated with Quality Indicators of Medication—MoPIM Cohort Study

Author:

Lleal MarinaORCID,Baré MarisaORCID,Ortonobes Sara,Sevilla-Sánchez DanielORCID,Jordana Rosa,Herranz Susana,Gorgas Maria Queralt,Espaulella-Ferrer MarionaORCID,Arellano Marta,de Antonio Marta,Nazco Gloria Julia,Hernández-Luis Rubén,

Abstract

Multimorbidity is increasing and poses a challenge to the clinical management of patients with multiple conditions and drug prescriptions. The objectives of this work are to evaluate if multimorbidity patterns are associated with quality indicators of medication: potentially inappropriate prescribing (PIP) or adverse drug reactions (ADRs). A multicentre prospective cohort study was conducted including 740 older (≥65 years) patients hospitalised due to chronic pathology exacerbation. Sociodemographic, clinical and medication related variables (polypharmacy, PIP according to STOPP/START criteria, ADRs) were collected. Bivariate analyses were performed comparing previously identified multimorbidity clusters (osteoarticular, psychogeriatric, minor chronic disease, cardiorespiratory) to presence, number or specific types of PIP or ADRs. Significant associations were found in all clusters. The osteoarticular cluster presented the highest prevalence of PIP (94.9%) and ADRs (48.2%), mostly related to anxiolytics and antihypertensives, followed by the minor chronic disease cluster, associated with ADRs caused by antihypertensives and insulin. The psychogeriatric cluster presented PIP and ADRs of neuroleptics and the cardiorespiratory cluster indicators were better overall. In conclusion, the associations that were found reinforce the existence of multimorbidity patterns and support specific medication review actions according to each patient profile. Thus, determining the relationship between multimorbidity profiles and quality indicators of medication could help optimise healthcare processes. Trial registration number: NCT02830425.

Funder

Instituto de Salud Carlos III-FEDER

Network for Research into Healthcare in Chronic Diseases, REDISSEC

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference63 articles.

1. A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology;Fortin;Ann. Fam. Med.,2012

2. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study;Barnett;Lancet,2012

3. The Academy of Medical Sciences (2018). Multimorbidity: A Priority For Global Health Research, The Academy of Medical Sciences. Available online: https://acmedsci.ac.uk/file-download/82222577.

4. Rijken, M., Struckmann, V., Van Der Heide, I., Hujala, A., Barbabella, F., Van Ginneken, E., and Schellevis, F. (2016). How to Improve Care For People with Multimorbidity in Europe?, European Observatory on Health Systems and Policies. Available online: https://www.euro.who.int/en/about-us/partners/observatory/publications/policy-briefs-and-summaries/how-to-improve-care-for-people-with-multimorbidity-in-europe.

5. Defining and measuring multimorbidity: A systematic review of systematic reviews;Johnston;Eur. J. Public Health,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3